Opportunity

Simpler Grants.gov #HT942526TBDRPIDA

Tick-Borne Disease Research Program Idea Development Award Research Grant Opportunity

Buyer

U.S. Army Medical Research Acquisition Activity

Posted

May 01, 2026

Respond By

October 22, 2026

Identifier

HT942526TBDRPIDA

NAICS

541715

The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is seeking innovative research proposals for the Tick-Borne Disease Research Program (TBDRP) Idea Development Award. - Government Buyer: - Department of the Army - US Army Medical Research Acquisition Activity (USAMRAA) - Purpose: - Fund conceptually innovative research projects targeting Lyme disease and other tick-borne diseases - Improve patient care and quality of life for those affected by tick-borne illnesses - Key Details: - Focus on new concepts, challenging existing paradigms, or novel approaches - Career Development Option available for early-career investigators, with mentorship and a lower cost limit - No specific OEMs or vendors are named, as this is a research grant opportunity - Total funding available: $3,500,000 - Up to five awards expected - Eligibility is unrestricted; no cost sharing or matching required - Notable Requirements: - Proposals must demonstrate innovation and potential for significant impact - Separate evaluation process for Career Development Option applicants - No products or equipment are being procured; this is a grant for research services only

Description

The fiscal year 2026 Tick-Borne Disease Research Program Idea Development Award aims to support conceptually innovative research that could lead to impactful discoveries or significant advancements in reducing the burden of Lyme disease and other tick-borne diseases. The research should introduce new concepts, challenge existing paradigms, or approach issues from new perspectives rather than incremental advances. A Career Development Option is available for early-career investigators under mentorship, with separate evaluation criteria and a lower cost limit. The award is unrestricted in eligibility and seeks to improve patient care and quality of life related to tick-borne diseases.

View original listing